E-Briefings

The Precision Medicine Institute's E-briefings deliver news and intelligence articles about the latest precision medicine topics to keep health system, hospital, and medical executives and administrators on the cutting edge of this rapidly changing field

Explore E-Briefings

E-briefings are published weekly and are listed below, with the most recent at the top. You may filter by topic and access dozens of additional articles using the page navigation below. Check back often to access new articles online or subscribe to have each new article delivered straight to your inbox weekly!

New Saliva Protein Database Pairs With Human Disease Studies to Advance Precision Medicine Possibilities

Research now links human saliva proteins in a multitude of ways. With saliva signatures recognized by thousands of identifiable proteins, a new public database that catalogs and curates this data in relation to disease studies offers a promising resource for hospitals.

Precision Medicine Using AI-Powered Dosing Provides Innovative Way for Hospitals to Reduce Medication Expenses

With a new Kidney Care Choices model starting January 1, 2022, hospital executives may be considering strategies, including precision medicine strategies.

Israeli Researchers Use 3D Bio-Printing to Determine Best Precision Medicine Cancer Treatments

A new 3D bio-printing method marks an exciting beginning to precision medicine treatments for highly-aggressive glioblastoma cancer.

Massachusetts General Hospital Sees Success With AI-Based Precision Medicine Breast Cancer Screening

Breast imagers are uniquely positioned to lead the way in AI cancer screening through their extensive experience with computer-assisted diagnosis (CAD), stated Constance Lehman, MD, PhD, a diagnostic radiologist, Professor of Radiology at Harvard Medical School, and Director of Breast Imaging at MGH.

Rapid Genetic Sequencing Saves the Life of an Infant With a Rare Fatal Brain Disease

Research will continue toward the value and medical necessity of both WES and WGS where results directly influence medical management and clinical outcomes. As a result, reimbursement for the uses of these testing methods may be changing as more about their roles is learned.

Denmark Research Finds that a Combination of Genes Causes Medication Side Effects and Deficiencies in Most Patients

New research from Aarhus University, recently published in Translational Psychiatry, analyzed the frequency of genetic variations that affect drug metabolism and drug targets in over 77,000 patients. What the study found.

New Genetic Research Provides Most Significant Advance To Date in Genomic Reference Resources for Precision Medicine

“With these new reference data, genetic differences can be studied with unprecedented accuracy against the background of global genetic variation, which facilitates the biomedical evaluation of genetic variants carried by an individual,” said co-first author, Peter Ebert, PhD, a bioinformatics software engineer at the Institute for Medical Biometry and Bioinformatics at Heinrich Heine University.

New Precision Medicine Integrations in Epic’s EHR Offer Hospitals Opportunities to Improve Clinical Outcomes and Generate New Sources of Revenue

The new collaboration between Epic and Foundation Medicine integrates Foundation’s comprehensive genomic profiling (CGP) and other testing services with Epic’s electronic medical record (EMR) system. Genomic information will power clinical decision support.

UPenn Researchers Identify Genes Responsible for Kidney Function and Related Hypertension

Because of the increased number of risk adjustment programs, improved diagnosis and treatment of chronic kidney disease (CKD) could trigger substantial financial benefit. This research maps a path for physicians and health systems to better utilize existing medications for their patients with CKD.

Association for Molecular Pathology Calls on Hospitals to Support Precision Medicine Through the Sharing of Genetic Data

Statement comes at a time of recent draft legislation and “bipartisan support” for the creation of a new advanced research agency to cure cancer and currents of a “highly anticipated” 21st Century Cures 2.0 bill.